To further explore this hypothesis, we evaluated the gene expression of ADRA2A, ADRA2C, and ADRB2 in patients with localized BC (stage Ia) versus patients with advanced BC, comprising both locally advanced BC (stage IIIc) and metastatic BC (stage IV). Here, ADRA2C is linked to breast cancer.